In vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 1, 2000, Pages 181-182

  Fernández Roblas, Ricardo ^a   Esteban, Jaime ^a   Cabria, Froilán ^a   López, Juan Carlos ^a   Jiménez, Maria Soledad ^b   Soriano, Francisco ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; JOSAMYCIN; LEVOFLOXACIN; RIFAPENTINE; ROXITHROMYCIN; TELITHROMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIUM ISOLATION; DRUG EFFECT; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM FORTUITUM; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0342545983     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.1.181-182.2000     Document Type: Article

References (12)

1. Brown, B. A., R. J. Wallace, G. O. Onyi, V. D. Rosas, and R. J. Wallace III. 1992. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob. Agents Chemother. 36:180-184.
2. Horowitz, E. A., and W. E. Sanders. 1995. Other mycobacterium species, p. 2264-2273. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas and Bennett's principles and practice of infectious diseases, 4th ed. Churchill Livingstone, New York, N.Y.
3. Khardori, N., H. Nguyen, B. Rosenbaum, K. Rolston, and G. P. Bodey. 1994. In vitro susceptibilities of rapidly growing mycobacteria to newer antimicrobial agents. Antimicrob. Agents Chemother. 38:134-137.
4. Koontz, F. P., M. E. Erwin, M. S. Barrett, and R. N. Jones. 1994. Etest for routine clinical antimicrobial susceptibility testing of rapid-growing mycobacteria isolates. Diagn. Microbiol. Infect. Dis. 19:183-186.
5. Metchock, B. G., F. S. Nolte, and R. J. Wallace. 1999. Mycobacterium, p. 399-437. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. ASM Press, Washington, D.C.
6. Soriano, F., R. Fernández-Roblas, R. Calvo, and G. García-Calvo. 1998. In vitro susceptibilities of aerobic and facultative non-spore-forming gram-positive bacilli to HMR 3647 (RU 66647) and 14 other antimicrobials. Antimicrob. Agents Chemother. 42:1028-1033.
7. Swenson, J. M., C. Thornsberry, and V. A. Silcox. 1982. Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution. Antimicrob. Agents Chemother. 22:186-192.
8. Wallace, R. J., G. Bedsole, G. Sumter, C. V. Sanders, L. C. Steele, B. A. Brown, J. Smith, and D. R. Graham. 1990. Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob. Agents Chemother. 34:65-70.
9. Wallace, R. J., V. A. Silcox, M. Tsukamura, B. A. Brown, J. O. Kilburn, W. R. Butler, and G. Onyi. 1993. Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonaelike organism. J. Clin. Microbiol. 31:3231-3239.
10. Wallace, R. J., J. M. Swenson, V. A. Silcox, and M. G. Bullen. 1985. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J. Infect. Dis. 152:500-514.
11. Wallace, R. J., J. M. Swenson, V. A. Silcox, R. C. Good, J. A. Tschen, and M. S. Stone. 1983. Spectrum of disease due to rapidly growing mycobacteria. Rev. Infect. Dis. 5:657-679.
12. Watt, G. 1997. In-vitro sensitivities and treatment of less common mycobacteria. J. Antimicrob. Chemother. 39:567-574.